Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls

Neuroscience Letters

Volumn 224, Issue 2, 1997, Pages 99-102

  Hahne, Solveig ^a   Nordstedt, Christer ^a   Åhlin, Arne ^a   Nybäck, Henrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's dementia; amyloid; apolipoprotein E; cerebrospinal fluid

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; AMYLOID; APOLIPOPROTEINS E; BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT;

EID: 0030970749     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)13477-2     Document Type: Article

References (23)

1. Blennow, K., Hesse, C. and Fredman, P., Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease, NeuroReport, 5 (1994) 2534-2536.
2. Carlsson, J., Armstrong, V.W., Reiber, H., Felgenhauer, K. and Seidel, D., Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid, Clin. Chim. Acta, 196 (1991) 167-176.
3. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261 (1993) 921-923.
4. Landén, M., Hesse, C., Fredman, P., Regland, B., Wallin, A. and Blennow, K., Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform, Dementia, 7 (1996) 273-278.
5. Lefranc, D., Vermersch, P., Dallongeville, J., Daems-Monpeurt, C., Petit, H. and Delacourte, A., Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease, Neurosci. Lett., 212 (1996) 91-94.
6. Lehtimäki, T., Pirttilä, T., Wisniewski, H.M., Frey, H. and Nikkari, T., Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease, Hum. Genet., 95 (1995) 39-42.
7. Ma, J., Yee, A., Brewer, H.B.J., Das, S. and Potter, H., Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments, Nature, 372 (1994) 92-94.
8. McGeer, P.L. and Rogers, J., Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease, Neurology, 42 (1992) 447-449.
9. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34 (1984) 939-944.
10. Nybäck, H., Nyman, H. and Schalling, D., Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia, Acta Psyciatr. Scand., 76 (1987) 648-656.
11. Näslund, J., Thyberg, J., Tjernberg, L.O., Wernstedt, C., Karlström, A.R., Bogdanovic, N., Gandy, S.E., Lannfelt, L., Terenius, L. and Nordstedt, C., Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain, Neuron, 15 (1995) 219-228.
12. Pirttilä, T., Mehta, P.D., Soininen, H., Kim, K.S., Heinonen, O., Paljärvi, L., Kosunen, O., Riekkinen, P. Sr. and Wisniewski, H.M., Cerebrospinal fluid concentrations of soluble amyloid β-protein and apolipoprotein E in patients with Alzheimer's disease. Correlations with amyloid load in the brain, Arch. Neurol., 53 (1996) 189-193.
13. Pitas, R.E., Boyles, J.K., Lee, S.H., Hui, D. and Weisgraber, K.H., Lipoproteins and their receptors in the central nervous system: characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain, J. Biol. Chem., 262 (1987) 14352-14360.
14. Reisberg, B., Ferris, S.H., de Leon, M.J. and Crook, T., The global deterioration scale for assessment of primary degenerative dementia, Am. J. Psychiatry, 139 (1982) 1136-1139.
15. Rösler, N., Wichart, I. and Jellinger, K.A., Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer' s disease, J. Neurol. Neurosurg. Psychiatry, 60 (1996) 452-454.
16. Schägger, H. and von Jagow, G., Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa, Anal. Biochem., 166 (1987) 368-379.
17. Selkoe, D.J., The molecular pathology of Alzheimer's disease, Neuron, 6 (1991) 487-498.
18. Stone, M.J., Amyloidosis: a final common pathway for protein deposition in tissues, Blood, 75 (1990) 531-545.
19. Van Broeckhoven, C., Presenilins and Alzheimer disease, Nature Genet., 11 (1995) 230-232.
20. Warden, C.H., Hedrick, C.C., Qiao, J.-H., Castellani, L.W. and Lusis, A.J., Atherosclerosis in transgenic mice overexpessing apolipoprotein A-II, Science, 261 (1993) 469-472.
21. Wenham, P.R., Price, W.H. and Blandell, G., Apolipoprotein E genotyping by one-stage PCR, Lancet, 337 (1991) 1158-1159.
22. Wisniewski, T. and Frangione, B., Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid, Neurosci. Lett., 135 (1992) 235-238.
23. Wisniewski, T., Lalowski, M., Golabek, A., Vogel, T. and Frangione, B., Is Alzheimer's disease an apolipoprotein E amyloidosis?, Lancet, 345 (1995) 956-958.